Cleared Traditional

CarnaLife Holo (K221870) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221870 · Medapp S.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
307d
Days
Class 2
Risk

K221870 is an FDA 510(k) clearance for the CarnaLife Holo. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medapp S.A. (Krakow, PL). The FDA issued a Cleared decision on May 1, 2023 after a review of 307 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medapp S.A. devices

Submission Details

510(k) Number K221870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2022
Decision Date May 01, 2023
Days to Decision 307 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
200d slower than avg
Panel avg: 107d · This submission: 307d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Parexel International
Albert Pacheco

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 802
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K221870.
Neurophet AQUA
K220437 · Neurophet., Inc. · May 2023
Akunah REFLECT
K222987 · Akunah Pty, Ltd. · May 2023
3D Anatomic Model
K230119 · Ricoh USA, Inc. · May 2023
MR DWI/FLAIR Measurement V1.0
K230552 · Olea Medical · Apr 2023
Konicaminolta DI-X1
K230906 · Konica Minolta, Inc. · Apr 2023
EzDent Web
K230468 · Ewoosoft Co., Ltd. · Apr 2023